Full Text View
Tabular View
No Study Results Posted
Related Studies
GSK573719 IV Enabling Study
This study has been completed.
Study NCT01110018   Information provided by GlaxoSmithKline

First Received on April 15, 2010.   Last Updated on August 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Chronic Disease
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Disease Attributes
Lung Diseases, Obstructive
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
GSK573719 (SOLUTION)
GSK573719 (INHALATION POWDER)
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services